Practice Agreement
Build an agreement

Collaborative Practice Agreement · PharmD

Connecticut Collaborative Drug Therapy Management Agreement or Care Plan for Pharmacists

Required. The Collaborative Drug Therapy Management Agreement or Care Plan is the written instrument Connecticut law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.

Practice authoritySupervision required
Written agreementAgreement required
What Connecticut calls itCollaborative Drug Therapy Management Agreement or Care Plan
Governing boardConnecticut Commission of Pharmacy
Agreement familyCollaborative Practice
Research date2026-09-03 · clauses 2026-09-03

Represents Connecticut's pharmacist Collaborative Drug Therapy Management (CDTM) framework (§20-631), not ordinary licensure — base dispensing/counseling need no physician/APRN agreement and are out of scope here. Any 'qualified pharmacist' (competency requirement plus review of the national Pharmacists' Patient Care Process) may enter a CDTM agreement; no residency, board-certification, or numeric per-prescriber cap was found.

What a Connecticut Collaborative Drug Therapy Management Agreement or Care Plan must contain

Governed by the Connecticut Commission of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.

  1. The Pharmacist may practice under a collaborative drug therapy management agreement or care plan with the Physician, as authorized under Conn. Gen. Stat. § 20-631. Only a "qualified pharmacist" — one whom regulations of the Connecticut Department of Public Health deem competent, and who has reviewed the Pharmacists' Patient Care Process published by the Joint Commission of Pharmacy Practitioners — may serve as the collaborating pharmacist under such an agreement.

    Source: Conn. Gen. Stat. § 20-631

  2. The Collaborative Drug Therapy Management Agreement or Care Plan on file also carries 1 scope, 1 education, 1 registration, 1 authority clauses, generated in the document itself.

Terms it has to carry

Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

Not codified — left to the agreement

Prescriptive authority

Covered by the practice agreement · no controlled-substance authority

§20-631's CDTM authority text does not mention controlled substances at all — this research pass found no confirmation that CDTM extends to Schedule II-V drugs; treat controlledSubstancesAllowed as an unconfirmed 'no' from statutory silence rather than a settled exclusion. Pharmacist must notify the prescribing practitioner within 24 hours of any discontinuance/deprescribing.

Written agreement

Required

The prescribing practitioner (physician or APRN) must first establish a provider-patient relationship with the patient before the pharmacist may act under a CDTM agreement, care plan, or institutional CDTM policy (§20-631(b)).

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — No general pharmacist-ownership requirement — a pharmacy must be 'supervised and managed' by a full-time pharmacist-manager (§20-597), who retains professional control over dispensing, but the pharmacy itself may be non-pharmacist/corporate-owned.

One CT-specific restriction: no prescribing practitioner, their spouse (unless also a pharmacist), or their dependent child may hold an ownership/investment interest in a pharmacy (§20-596) — an anti-self-referral rule distinct from the CDTM clinical framework above.

Legal sources for these rules (4)
How the relationship works day to day
Who has to be where, how often you meet, and what the physician costs: Pharmacist in Connecticut on collaborativeagreement.com.

About Connecticut's rules

NP, CNS, and CRNA are all licensed as a single 'advanced practice registered nurse' category (§20-94a) sharing an identical 3-year/2,000-hour collaboration-to-independence pathway (§20-87a); CT does not statutorily distinguish PMHNP or CNS scope from general NP. CNMs are licensed separately (Ch. 377), with no written collaborative-agreement requirement. No provider type below has a codified supervision ratio cap, chart-review percentage, or on-site proximity radius outside CRNA's surgery-specific carve-out.

Other clinicians in Connecticut: see the state overview.